Literature DB >> 9761138

The impact on quality of life of patient-related barriers to pain management.

S E Ward1, K Carlson-Dakes, S H Hughes, K L Kwekkeboom, H S Donovan.   

Abstract

A stress-coping model of relationships between patients' beliefs about pain, coping (analgesic use), pain severity, analgesic side-effects, and three quality of life (QOL) outcomes was tested. Participants were 182 men and women with cancer who completed valid and reliable self-report measures of relevant variables. Antecedent variables (age and education) showed expected relationships with beliefs. As predicted, beliefs were significantly related to analgesic use. Analgesic use was inversely related to pain severity, but was not related to side-effect severity. Analgesic use was inversely related to impairments in QOL before controlling for pain and side-effect severity, but not after these two variables were controlled. Both analgesic side-effects and pain severity were related to impaired QOL outcomes, including difficulty performing life activities, depressed mood, and poor perceived health status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761138     DOI: 10.1002/(sici)1098-240x(199810)21:5<405::aid-nur4>3.0.co;2-r

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  28 in total

1.  Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress.

Authors:  Catherine E Mosher; Katherine N Duhamel; Jennifer Egert; Meredith Y Smith
Journal:  Clin J Pain       Date:  2010 Mar-Apr       Impact factor: 3.442

2.  Barriers to pain management among adolescents with cancer.

Authors:  Suzanne Ameringer
Journal:  Pain Manag Nurs       Date:  2009-09-12       Impact factor: 1.929

3.  A randomized trial of a representational intervention to decrease cancer pain (RIDcancerPain).

Authors:  Sandra Ward; Heidi Donovan; Sigridur Gunnarsdottir; Ronald C Serlin; Gary R Shapiro; Susan Hughes
Journal:  Health Psychol       Date:  2008-01       Impact factor: 4.267

4.  An update on the representational approach to patient education.

Authors:  Heidi Scharf Donovan; Sandra E Ward; Mi-Kyung Song; Susan M Heidrich; Sigridur Gunnarsdottir; Christopher M Phillips
Journal:  J Nurs Scholarsh       Date:  2007       Impact factor: 3.176

5.  The influence of psychosocial factors on quality of life among women with pain: a prospective study in Sweden.

Authors:  Johanna Thomtén; Joaquim J F Soares; Örjan Sundin
Journal:  Qual Life Res       Date:  2011-02-03       Impact factor: 4.147

6.  Adherence to Analgesics for Cancer Pain: A Comparative Study of African Americans and Whites Using an Electronic Monitoring Device.

Authors:  Salimah H Meghani; Aleda M L Thompson; Jesse Chittams; Deborah W Bruner; Barbara Riegel
Journal:  J Pain       Date:  2015-06-14       Impact factor: 5.820

7.  The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control.

Authors:  Marlene Z Cohen; Catherine F Musgrave; Deborah B McGuire; Neville E Strumpf; Mark F Munsell; Tito R Mendoza; Maya Gips
Journal:  Support Care Cancer       Date:  2005-02-19       Impact factor: 3.603

8.  Pain barriers: psychometrics of a 13-item questionnaire.

Authors:  Debra Boyd-Seale; Diana J Wilkie; Young Ok Kim; Marie L Suarez; Hilary Lee; Robert Molokie; Zhongsheng Zhao; Shiping Zong
Journal:  Nurs Res       Date:  2010 Mar-Apr       Impact factor: 2.381

9.  Relationships between three beliefs as barriers to symptom management and quality of life in older breast cancer survivors.

Authors:  Hyun-E Yeom; Susan M Heidrich
Journal:  Oncol Nurs Forum       Date:  2013-05-01       Impact factor: 2.172

10.  A pilot study to identify correlates of intentional versus unintentional nonadherence to analgesic treatment for cancer pain.

Authors:  Salimah H Meghani; Deborah Watkins Bruner
Journal:  Pain Manag Nurs       Date:  2011-05-06       Impact factor: 1.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.